Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul;23(7):767-768.
doi: 10.1016/S1473-3099(23)00119-6. Epub 2023 Mar 10.

The ups and downs of observational vaccine research

Affiliations
Comment

The ups and downs of observational vaccine research

Noam Barda. Lancet Infect Dis. 2023 Jul.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Chemaitelly H, Ayoub HH, Tang P, et al. Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study. Lancet Infect Dis. 2023 doi: 10.1016/S1473-3099(23)00058-0. published online March 10. - DOI - PMC - PubMed
    1. Barda N, Dagan N. The role of observational studies based on secondary data in studying SARS-CoV-2 vaccines. Clin Microbiol Infect. 2022;28:313–314. - PMC - PubMed
    1. Kahn R, Schrag SJ, Verani JR, Lipsitch M. Identifying and alleviating bias due to differential depletion of susceptible people in postmarketing evaluations of COVID-19 vaccines. Am J Epidemiol. 2022;191:800–811. - PMC - PubMed
    1. Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21:383–388. - PMC - PubMed
    1. Gagne M, Moliva JI, Foulds KE, et al. mRNA-1273 or mRNA-omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from omicron. Cell. 2022;185:1556. 71.e18. - PMC - PubMed

Publication types